Holistic Consideration of Patients with Schizophrenia to Improve Medication Adherence and Outcomes [0.03%]
整体考虑精神病患者以提高依从性及临床结局
Lan-Ting Lee,Kao Chin Chen,Wei Hung Chang et al.
Lan-Ting Lee et al.
Although several algorithms have been applied to treat patients with schizophrenia, their clinical use remains still limited, because most emphasize the prescription of antipsychotics. A new algorithm with a more holistic approach to treati...
Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders [0.03%]
ω-3多不饱和脂肪酸在 mood 和 anxiety disorder 一级预防中的作用
Kuan-Pin Su,Yutaka Matsuoka,Chi-Un Pae
Kuan-Pin Su
Psychiatric disorders in general, and major depression and anxiety disorders in particular, account for a large burden of disability, morbidity and premature mortality worldwide. Omega-3 polyunsaturated fatty acids (PUFAs) have a range of n...
A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder [0.03%]
长效抗精神病药物治疗双相障碍系统综述及专家共识
Yuan Hwa Chou,Po-Chung Chu,Szu-Wei Wu et al.
Yuan Hwa Chou et al.
Bipolar disorder (BD) is a major psychiatric disorder that is easily misdiagnosed. Patient adherence to a treatment regimen is of utmost importance for successful outcomes in BD. Several trials of antipsychotics suggested that depot antipsy...
Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression [0.03%]
用异氟醚或莨菪碱联合笑气治疗难治性抑郁症
Chun Yang,Kenji Hashimoto
Chun Yang
Dystonia in an adolescent on risperidone following the discontinuation of methylphenidate: a case report [0.03%]
一名此前服用哌甲酯后停药的利培酮青少年患者的扭转痉挛病例报告
Gulen Guler,Veli Yildirim,Meryem Ozlem Kutuk et al.
Gulen Guler et al.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with common comorbidities that include oppositional defiant disorder, conduct disorder, anxiety disorder, and affective disorders. Because of these comorbiditi...
Amlan Kusum Jana,Samir Kumar Praharaj,Nirmalya Roy
Amlan Kusum Jana
Olanzapine is an atypical antipsychotic which is efficacious in the treatment of schizophrenia. The adverse effect profile for olanzapine is benign except for higher rates of metabolic events. Orthostatic hypotension is less commonly report...
Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series [0.03%]
东莨菪碱溴化丁基对氯氮平所致流涎的病例分析系列研究
Ippei Takeuchi,Tatsuyo Suzuki,Taro Kishi et al.
Ippei Takeuchi et al.
Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0- 97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation...
The Relationship between Cognitive Decline and Psychopathology in Patients with Schizophrenia and Bipolar Disorder [0.03%]
精神分裂症和双相情感障碍患者认知下降与精神病理学之间的关系
Moon-Doo Kim,Hye-Jin Seo,Hyun-Ju Yun et al.
Moon-Doo Kim et al.
Objective: The primary goals of the present study were to assess intellectual function in participants with schizophrenia or bipolar disorder (BD) and to investigate the relationships between cognitive decline and the sev...
Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder [0.03%]
精神分裂症和双相情感障碍的神经认知共病表型及特异表型
Dohoon Kim,Ji-Woo Kim,Tae-Hoon Koo et al.
Dohoon Kim et al.
Objective: Schizophrenia and bipolar disorder are characterized by the presence of neurocognitive impairments on the psychosis continuum. The present study aimed to explore the shared and distinct endophenotypes between t...
The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach [0.03%]
左乙拉西坦对健康人认知表现的影响：神经心理、行为和电生理学的方法研究
Julio Cesar Magalhães,Mariana Gongora,Renan Vicente et al.
Julio Cesar Magalhães et al.
Objective: The present study sought to analyze the influence of Levetiracetam (LEV) in cognitive performance by identifying the changes produced by LEV in reaction time, in neuropsychological assessment of attention and m...